Search Results - "Harlozinska, A"

Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients’ survival by Dorn, J., Magdolen, V., Gkazepis, A., Gerte, T., Harlozinska, A., Sedlaczek, P., Diamandis, E.P., Schuster, T., Harbeck, N., Kiechle, M., Schmitt, M.

“…Effective cancer biomarkers for early detection, prognosis, or therapy response prediction are urgently needed in ovarian cancer. Kallikrein-related…”
Get full text

Prognostic Significance of CA 125 and TPS Levels after 3 Chemotherapy Courses in Ovarian Cancer Patients by van Dalen, A., Favier, J., Burges, A., Hasholzner, U., de Bruijn, H.W.A., Dobler-Girdziunaite, D., Dombi, V.H., Fink, D., Giai, M., McGing, P., Harlozinska, A., Kainz, Ch, Markowska, J., Molina, R., Sturgeon, C., Bowman, A., Einarsson, R.

“…Objective. To evaluate the prognostic significance of and predictive value for survival of CA 125 and TPS levels after three chemotherapy courses in ovarian…”
Get full text

Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up by van Dalen, A, Favier, J, Hallensleben, E, Burges, A, Stieber, P, de Bruijn, H W A, Fink, D, Ferrero, A, McGing, P, Harlozinska, A, Kainz, Ch, Markowska, J, Molina, R, Sturgeon, C, Bowman, A, Einarsson, R, Goike, H

“…To evaluate the prognostic significance for overall survival rate for the marker combination TPS and CA125 in ovarian cancer patients after three chemotherapy…”
Get more information

Morphological and phenotypic characterization of a new established ovarian carcinoma cell line (OvBH-1) by Bar, J K, Harlozińska, A

“…A limited number of permanent ovarian carcinoma cell lines have been described so far and the majority of them have been derived from ovarian ascitic fluid…”
Get more information

Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis by Slesak, B, Harlozinska, A, Porebska, I, Bojarowski, T, Lapinska, J, Rzeszutko, M, Wojnar, A

“…The expression and coexpression of EGFR, c-erbB-2 and c-erbB-3 in 21 gastric cancers and 20 chronic gastritis was examined using immunohistochemistry on fresh…”
Get more information

Field effect of human colon carcinoma on normal mucosa: relevance of carcinoembryonic antigen expression by Jothy, S, Slesak, B, Harłozińska, A, Lapińska, J, Adamiak, J, Rabczyński, J

“…Human colon cancer usually develops on a mucosa which has already undergone multiple steps of genetic change. These multiple steps create a field effect…”
Get more information

Progress in Molecular Mechanisms of Tumor Metastasis and Angiogenesis by HARLOZINSKA, Antonina

“…The development of metastases is the major cause of death for cancer patients, however, the mechanisms of tumor invasion and acquisition of capability to…”
Get full text

Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas by Porebska, I, Harlozińska, A, Bojarowski, T

“…The overexpression of three growth factor receptors: epidermal growth factor receptor (EGFR), ERB B2 and ERB B3 was evaluated immunohistochemically in 77…”
Get more information

Prospective studies of p53 and c-erbB-2 expression in relation to clinicopathological parameters of human ductal breast cancer in the second stage of clinical advancement by Bebenek, M, Bar, J K, Harlozinska, A, Sedlaczek, P

“…The association between p53 and c-erbB-2 overexpression relation to ER status in ductal breast carcinoma is still unclear. Our aim was investigate the…”
Get more information

Expression and mutation of p53 in tumor effusion cells of patients with ovarian carcinoma: response to cisplatin-based chemotherapy by Bar, J K, Harłozińska, A, Popiela, A, Noga, L

“…p53 alterations are considered as one of the most important factors responsible for drug resistance in ovarian carcinomas, although the relationship between…”
Get more information

Serum levels of CA 125 and TPS during treatment of ovarian cancer by Van Dalen, A, Favier, J, Baumgartner, L, Hasholzner, U, De Bruijn, H, Dobbler, D, Dombi, V H, Fink, D, Giai, M, McGing, P, Harlozinska, A, Kainz, C, Markowska, J, Molina, R, Sturgeon, C, Bowman, A, Einarsson, R

“…Two hundred and sixty ovarian cancer patients (including all FIGO stages) were enrolled in a prospective multicentre study. In this interim study we analyzed…”
Get more information

Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients by van Dalen, A, Favier, J, Baumgartner, L, Hasholzner, U, de Bruijn, H, Dobbler, D, Dombi, V H, Fink, D, Giai, M, McGing, P, Harlozinska, A, Kainz, C, Markowska, J, Molina, R, Sturgeon, C, Einarsson, R

“…The analysis of survival data of patients with epithelial ovarian cancer proved that both CA 125 and TPS were good markers for clinical outcome prediction…”
Get more information

Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series by NOWOROLSKA, A, HARŁOZINSKA, A, RICHTER, R, BRODZKA, W

“…The distribution and localization of NCA and carcinoembryonic antigen CEA in cells of different types of myelogenous leukaemias (acute myelogenous leukaemia -…”
Get full text

Relationship between p53 and c-erbB-2 overexpression in tissue sections and cyst fluid cells of patients with ovarian cancer by Harłozińska, A, Bar, J K

“…The expression of p53 protein and overexpression of c-erbB-2 oncoprotein was examined immunohistochemically and compared on frozen tissue sections and cyst…”
Get more information

The diagnostic dilemmas in discrimination between pancreatic carcinoma and chronic pancreatitis by Harlozinska-Szmyrka, A, Strutynska-Karpinska, M

“…The diagnostic dilemmas in discrimination between pancreatic carcinoma and chronic pancreatitis Early diagnosis to distinguish between malignant pancreatic…”
Get full text

Studies on tumor proliferation using monoclonal antibody, Ki 67 and expression of p53 in cancer of the uterine cervix by Bar, J K, Harlozinska, A, Markowska, J, Nowak, M

“…The analyzed material included 41 sections originating from patients with squamous cell carcinoma at the III stage of clinical advancement. Size of tumor…”
Get more information

Relations between the expression of p53, c-erbB-2, Ki-67 and HPV infection in cervical carcinomas and cervical dysplasias by Bar, J K, Harłozińska, A, Sedlaczek, P, Kasiak, J, Markowska, J

“…The analysis of mutual relations between HPV infection and the expression of cancer gene products and proliferative activity in cervical carcinomas and…”
Get more information

Expression of p53 and coexistence of HPV in premalignant lesions and in cervical cancer by Markowska, J, Nowak, M, Bar, M, Harlozinska, A

“…Fifty-four paraffin embedded tissue sections from patients with dysplasia (21 cases) and with cervical cancer (33 cases) were analysed. HPV was detected and…”
Get more information

Relation between ovarian carcinoma-associated antigens in tumor tissue and detached cyst fluid cells of patients with ovarian neoplasms by Bar, J K, Harłozińska, A, Sobańska, E, Cislo, M

“…The expression and potential diagnostic value of ovarian carcinoma-associated antigens were estimated in different types of epithelial ovarian neoplasms. The…”
Get more information

CEA and NCA levels in peripheral and tumour venous blood of patients with gastric and colonic carcinomas estimated by RIA and EIA methods by Harłozińska, A, Rachel, F, Gawlikowski, W, Richter, R, Kołodziej, J

“…Carcinoembryonic antigen (CEA) and nonspecific cross-reacting antigen (NCA) levels in draining tumour blood were compared with concentrations of these antigens…”
Get more information